Iqvia Holdings (NYSE: IQV)
Iqvia Holdings Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Iqvia Holdings Company Info
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
News & Analysis
Top Biotech ETFs to Buy Now
Here are the five best biotech ETFs to invest in right now.
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
These healthcare companies' revenue and earnings have grown, and they expect more growth.
Forget IQVIA, Veeva Systems Is a Better Growth Stock
Here’s why Veeva Systems is the better choice for investors looking for exposure to companies performing clinical trial analytics.
Will COVID-19 Derail New Drugs?
Disruptions in clinical trials and delayed regulatory decisions could slow the rate of new drug approvals.
Is IQVIA Holdings Stock a Buy?
Headwinds from COVID-19 may negatively impact 2020 projections.
4 Healthcare Services Companies to Own for the Future
Many investors aren’t aware of the vital roles contract research organizations fulfill for pharmaceutical and biotech companies -- or of the billions they make each year for their services.
3 Top Biotech Stocks to Buy in August
In the high-risk world of biotech investing, there are no guarantees of success. Still, sometimes investors can find places where the odds look reasonable enough to consider buying shares.
IQVIA Holdings Boosts Guidance After a Strong Quarter
Everything is going well for the life sciences service provider.
Valuation
Earnings Transcripts
IQVIA Holdings, Inc. (IQV) Q2 2022 Earnings Call Transcript
IQV earnings call for the period ending June 30, 2022.
IQVIA Holdings, Inc. (IQV) Q1 2022 Earnings Call Transcript
IQV earnings call for the period ending March 31, 2022.
IQVIA Holdings, Inc. (IQV) Q4 2021 Earnings Call Transcript
IQV earnings call for the period ending December 31, 2021.
IQVIA Holdings inc (IQV) Q3 2021 Earnings Call Transcript
IQV earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.